JP2022516555A5 - - Google Patents
Info
- Publication number
- JP2022516555A5 JP2022516555A5 JP2021538976A JP2021538976A JP2022516555A5 JP 2022516555 A5 JP2022516555 A5 JP 2022516555A5 JP 2021538976 A JP2021538976 A JP 2021538976A JP 2021538976 A JP2021538976 A JP 2021538976A JP 2022516555 A5 JP2022516555 A5 JP 2022516555A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- membered
- aryl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788722P | 2019-01-04 | 2019-01-04 | |
| US62/788,722 | 2019-01-04 | ||
| US201962863853P | 2019-06-19 | 2019-06-19 | |
| US62/863,853 | 2019-06-19 | ||
| PCT/US2020/012260 WO2020142742A1 (en) | 2019-01-04 | 2020-01-03 | Inhibitors of fibroblast activation protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022516555A JP2022516555A (ja) | 2022-02-28 |
| JP2022516555A5 true JP2022516555A5 (https=) | 2023-01-11 |
Family
ID=71404153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538976A Pending JP2022516555A (ja) | 2019-01-04 | 2020-01-03 | 線維芽細胞活性化タンパク質の阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200216417A1 (https=) |
| EP (1) | EP3906024A4 (https=) |
| JP (1) | JP2022516555A (https=) |
| KR (1) | KR20210113634A (https=) |
| CN (1) | CN114126597A (https=) |
| AU (1) | AU2020204714A1 (https=) |
| BR (1) | BR112021011861A2 (https=) |
| CA (1) | CA3124525A1 (https=) |
| CL (1) | CL2021001739A1 (https=) |
| IL (1) | IL284434A (https=) |
| MX (1) | MX2021007948A (https=) |
| SG (1) | SG11202106399XA (https=) |
| WO (1) | WO2020142742A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116474108A (zh) | 2016-12-14 | 2023-07-25 | 普渡研究基金会 | 成纤维细胞活化蛋白(fap)-靶向成像和治疗 |
| US11780821B2 (en) | 2017-12-15 | 2023-10-10 | Praxis Biotech LLC | Inhibitors of fibroblast activation protein |
| WO2019126731A1 (en) | 2017-12-22 | 2019-06-27 | Petra Pharma Corporation | Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors |
| US11504364B2 (en) | 2018-12-21 | 2022-11-22 | Praxis Biotech LLC | Inhibitors of fibroblast activation protein |
| TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
| BR112021025637A2 (pt) | 2019-06-19 | 2022-02-01 | Nmd Pharma As | Compostos para o tratamento de doenças neuromusculares |
| EP4096677A4 (en) * | 2020-01-31 | 2024-02-28 | Purdue Research Foundation | Fibroblast activation protein (fap) - targeted antifibrotic therapy |
| CN115819443B (zh) * | 2022-08-02 | 2025-03-21 | 中国科学院上海应用物理研究所 | 一种含烯基化合物及其应用 |
| WO2025159534A1 (ko) * | 2024-01-24 | 2025-07-31 | 서울대학교산학협력단 | 3-스티릴피리딘 구조 기반의 섬유아세포 활성화 단백질 표적 물질 |
| CN118978511A (zh) * | 2024-08-02 | 2024-11-19 | 江苏华益科技有限公司 | 一种靶向fap化合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7399869B2 (en) * | 2005-05-19 | 2008-07-15 | Genentech, Inc. | Fibroblast activation protein inhibitor compounds and methods |
| CA2617715A1 (en) * | 2005-08-11 | 2007-02-15 | F. Hoffmann-La Roche Ag | Pharmaceutical composition comprising a dpp-iv inhibitor |
| WO2013107820A1 (en) * | 2012-01-17 | 2013-07-25 | Universiteit Antwerpen | Novel fap inhibitors |
| US11780821B2 (en) * | 2017-12-15 | 2023-10-10 | Praxis Biotech LLC | Inhibitors of fibroblast activation protein |
| US11504364B2 (en) * | 2018-12-21 | 2022-11-22 | Praxis Biotech LLC | Inhibitors of fibroblast activation protein |
-
2020
- 2020-01-03 JP JP2021538976A patent/JP2022516555A/ja active Pending
- 2020-01-03 CN CN202080007971.2A patent/CN114126597A/zh active Pending
- 2020-01-03 SG SG11202106399XA patent/SG11202106399XA/en unknown
- 2020-01-03 MX MX2021007948A patent/MX2021007948A/es unknown
- 2020-01-03 WO PCT/US2020/012260 patent/WO2020142742A1/en not_active Ceased
- 2020-01-03 AU AU2020204714A patent/AU2020204714A1/en not_active Abandoned
- 2020-01-03 BR BR112021011861-6A patent/BR112021011861A2/pt not_active Application Discontinuation
- 2020-01-03 KR KR1020217024699A patent/KR20210113634A/ko not_active Ceased
- 2020-01-03 EP EP20735966.2A patent/EP3906024A4/en not_active Withdrawn
- 2020-01-03 US US16/734,214 patent/US20200216417A1/en not_active Abandoned
- 2020-01-03 CA CA3124525A patent/CA3124525A1/en active Pending
-
2021
- 2021-06-28 IL IL284434A patent/IL284434A/en unknown
- 2021-06-29 CL CL2021001739A patent/CL2021001739A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022516555A5 (https=) | ||
| JP2022514352A5 (https=) | ||
| IL275333B2 (en) | Inhibitors of fibroblast activation protein | |
| KR102709127B1 (ko) | Fak 억제제 및 그 약물 조합물 | |
| EP1339458B1 (en) | Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity | |
| RU2008136188A (ru) | Противораковая фармацевтическая композиция | |
| JP2007501238A (ja) | 癌の治療および阻害のための上皮増殖因子受容体キナーゼ阻害剤と細胞障害性物質との組み合わせの使用 | |
| JP2024524373A5 (https=) | ||
| RU2008115454A (ru) | Противоопухолевые комбинации с ингибиторами mtor, герцептином и/или hki-272 | |
| RU2010150786A (ru) | Пирролопиридины как ингибиторы киназы | |
| JP2003523381A (ja) | 投与レジメン | |
| ZA200307665B (en) | Combination comprising N-{5-[4-(4-methyl-piperazinomethyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and a chemotherapeutic agent. | |
| KR20210095721A (ko) | 인돌리논 화합물의 용도 | |
| JP2021514395A5 (https=) | ||
| KR102748684B1 (ko) | 술폰아미드 화합물과 면역 조절제를 사용하는 암 병용 요법 | |
| JP2023509359A5 (https=) | ||
| CA2496688A1 (en) | Glycinamide derivatives as raf-kinase inhibitors | |
| JP2003525239A (ja) | タキサン化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤 | |
| WO2022092085A1 (ja) | 腫瘍治療用医薬組成物 | |
| RU2007126746A (ru) | Новые производные гидантоина в качестве ингибиторов металлопротеиназ | |
| JP2005515967A5 (https=) | ||
| WO2020187188A1 (zh) | 喹啉衍生物及免疫调节剂联合在制备抗肿瘤药物中的应用 | |
| TW202102216A (zh) | 抗腫瘤組合物 | |
| JP2008527039A5 (https=) | ||
| RU2021121980A (ru) | Ингибиторы белка активации фибробластов |